Total Payments
$715,948
2024 Payments
$9,700
Companies
30
Transactions
1,122
Medicare Patients
733
Medicare Billing
$254,839
Payment Breakdown by Category
Other$615,087 (85.9%)
Consulting$56,953 (8.0%)
Travel$25,221 (3.5%)
Food & Beverage$18,189 (2.5%)
Education$498.99 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $613,293 | 342 | 85.7% |
| Consulting Fee | $56,953 | 24 | 8.0% |
| Travel and Lodging | $25,221 | 218 | 3.5% |
| Food and Beverage | $18,189 | 531 | 2.5% |
| Honoraria | $1,750 | 1 | 0.2% |
| Education | $498.99 | 5 | 0.1% |
| Grant | $43.95 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $212,983 | 280 | $0 (2024) |
| Amgen Inc. | $123,477 | 163 | $0 (2021) |
| Allergan, Inc. | $110,006 | 148 | $0 (2022) |
| ABBVIE INC. | $105,746 | 157 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $46,897 | 129 | $0 (2024) |
| Depomed, Inc. | $31,953 | 51 | $0 (2017) |
| Promius Pharma LLC | $30,373 | 52 | $0 (2019) |
| IMPEL PHARMACEUTICALS INC. | $14,870 | 11 | $0 (2023) |
| Avanir Pharmaceuticals, Inc. | $13,186 | 24 | $0 (2019) |
| Assertio Therapeutics, Inc. | $9,814 | 14 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9,700 | 20 | ABBVIE INC. ($9,379) |
| 2023 | $26,799 | 31 | ABBVIE INC. ($26,081) |
| 2022 | $78,307 | 105 | ABBVIE INC. ($35,931) |
| 2021 | $89,019 | 118 | AbbVie Inc. ($34,354) |
| 2020 | $133,248 | 144 | Lilly USA, LLC ($81,324) |
| 2019 | $149,004 | 313 | Lilly USA, LLC ($58,026) |
| 2018 | $147,165 | 236 | Amgen Inc. ($57,475) |
| 2017 | $82,708 | 155 | Depomed, Inc. ($31,953) |
All Payment Transactions
1,122 individual payment records from CMS Open Payments — Page 1 of 45
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | ABBVIE INC. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | Cash or cash equivalent | $119.27 | General |
| Category: Neuroscience | ||||||
| 11/05/2024 | ABBVIE INC. | QULIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: NEUROSCIENCE | ||||||
| 09/27/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $112.09 | General |
| Category: NEUROLOGY | ||||||
| 06/13/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: PAIN | ||||||
| 05/16/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $6.69 | General |
| Category: NEUROSCIENCE | ||||||
| 05/07/2024 | ABBVIE INC. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/01/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: NEUROSCIENCE | ||||||
| 04/23/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $30.88 | General |
| Category: NEUROSCIENCE | ||||||
| 04/16/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,312.50 | General |
| Category: NEUROSCIENCE | ||||||
| 04/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $27.19 | General |
| Category: Central Nervous System | ||||||
| 02/22/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: PAIN | ||||||
| 02/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.89 | General |
| Category: NEUROSCIENCE | ||||||
| 02/14/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $26.06 | General |
| Category: Central Nervous System | ||||||
| 01/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $28.92 | General |
| Category: NEUROSCIENCE | ||||||
| 12/21/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/15/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: NEUROSCIENCE | ||||||
| 11/28/2023 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,000.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/09/2023 | Scilex Pharmaceuticals Inc. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: Analgesic | ||||||
| 09/15/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 154 | 7,402 | $101,895 | $55,238 |
| 2022 | 7 | 195 | 9,281 | $133,408 | $70,149 |
| 2021 | 8 | 223 | 10,514 | $143,478 | $78,326 |
| 2020 | 6 | 161 | 7,004 | $95,576 | $51,126 |
Total Patients
733
Total Services
34,201
Medicare Billing
$254,839
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 12 | 7,200 | $47,736 | $35,723 | 74.8% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 14 | 41 | $12,931 | $4,485 | 34.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 25 | 25 | $10,524 | $4,396 | 41.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 50 | $10,816 | $3,074 | 28.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 20 | $5,888 | $2,628 | 44.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $6,090 | $2,285 | 37.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 34 | $4,975 | $1,819 | 36.6% |
| 64405 | Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | Office | 2023 | 11 | 14 | $2,936 | $829.50 | 28.3% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 15 | 9,004 | $59,697 | $44,066 | 73.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 44 | 44 | $18,522 | $6,836 | 36.9% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 17 | 52 | $16,401 | $5,757 | 35.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 44 | 70 | $15,142 | $5,060 | 33.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 35 | 69 | $10,096 | $3,833 | 38.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 27 | 27 | $9,134 | $3,248 | 35.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 15 | $4,416 | $1,350 | 30.6% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 18 | 10,200 | $67,626 | $48,808 | 72.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 63 | 78 | $16,872 | $6,634 | 39.3% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2021 | 19 | 54 | $17,032 | $6,380 | 37.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 43 | 86 | $12,584 | $5,756 | 45.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 33 | 33 | $11,164 | $3,958 | 35.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 18 | 19 | $5,594 | $2,554 | 45.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 16 | 16 | $6,735 | $2,540 | 37.7% |
| 64405 | Injection of anesthetic agent and/or steroid into greater occipital nerve of upper neck and back of head | Office | 2021 | 13 | 28 | $5,871 | $1,696 | 28.9% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2020 | 13 | 6,800 | $45,084 | $32,996 | 73.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 53 | 70 | $15,142 | $5,557 | 36.7% |
About Dr. Randolph Evans, MD
Dr. Randolph Evans, MD is a Neurology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1780684076.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Randolph Evans, MD has received a total of $715,948 in payments from pharmaceutical and medical device companies, with $9,700 received in 2024. These payments were reported across 1,122 transactions from 30 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($613,293).
As a Medicare-enrolled provider, Evans has provided services to 733 Medicare beneficiaries, totaling 34,201 services with total Medicare billing of $254,839. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Houston, TX
- Active Since 07/28/2005
- Last Updated 08/29/2011
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1780684076
Products in Payments
- EMGALITY (Drug) $106,462
- UBRELVY (Drug) $99,639
- Aimovig (Biological) $94,048
- BOTOX (Biological) $81,525
- REYVOW (Drug) $46,100
- Cambia (Drug) $33,069
- Zembrace (Drug) $27,278
- AJOVY (Drug) $25,110
- BOTOX (Drug) $20,153
- AJOVY (Biological) $17,495
- Trudhesa (Drug) $14,870
- QULIPTA (Drug) $11,250
- ONZETRA Xsail (Drug) $11,161
- Gralise (Drug) $8,629
- NURTEC ODT (Drug) $7,235
- AIMOVIG (Biological) $6,085
- ZEMBRACE SYMTOUCH (Drug) $3,094
- BOTOX CHRONIC MIGRAINE (Drug) $3,014
- VYEPTI (Biological) $1,862
- ONZETRA (Drug) $1,125
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Houston
William Ondo, M.d, M.D
Neurology — Payments: $1.5M
Neurology $1.5M
Dr. Annette Howard, Md, MD
Neurology — Payments: $1.2M
Neurology $1.2M
Paul Schulz, M.d, M.D
Neurology — Payments: $943,067
Neurology $943,067
Amit Verma, Md, MD
Neurology — Payments: $817,815
Neurology $817,815
Dr. John Volpi, Md, MD
Neurology — Payments: $569,676
Neurology $569,676
Jerry Wolinsky, M.d, M.D
Neurology — Payments: $556,693
Neurology $556,693